Biotech companies in the United States by dividend yield
Dividends paid over the last twelve months as a share of today's price.
Amgen leads the 20 biotech companies in the United States ranked by dividend yield, at 2.24%, ahead of Gilead Sciences (1.92%) and Bio-Techne (0.33%). Figures as of 20 Nov 2026, 12:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Amgen2.24%
- Median
- 0.00%
- Combined market value
- ZAR 12.84T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Dividend yield ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | 2.24% | ZAR 4.15T | ZAR 7,664.81 | 1.14% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | 1.92% | ZAR 3.61T | ZAR 2,908.76 | 1.45% down | 31% up | ||
| 3 | Bio-TechneTECH · Health Care | 0.33% | ZAR 199.5B | ZAR 1,269.84 | 0.07% down | 18% up | ||
| 4 | ModernaMRNA · Health Care | 0.00% | ZAR 1.41T | ZAR 3,481.67 | 1.29% up | 740% up | ||
| 5 | BiogenBIIB · Health Care | 0.00% | ZAR 638.1B | ZAR 4,316.59 | 1.70% down | 41% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | 0.00% | ZAR 602.3B | ZAR 2,784.74 | 0.24% down | 125% up | ||
| 7 | ExelixisEXEL · Health Care | 0.00% | ZAR 280.6B | ZAR 1,149.84 | 3.60% down | 55% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | 0.00% | ZAR 276.8B | ZAR 2,735.14 | 3.85% down | 10% up | ||
| 9 | RepligenRGEN · Health Care | 0.00% | ZAR 190.1B | ZAR 2,974.43 | 1.38% down | 5% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | 0.00% | ZAR 185.3B | ZAR 1,625.12 | 2.88% down | 32% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | 0.00% | ZAR 178B | ZAR 2,085.37 | 1.44% down | 81% up | ||
| 12 | Krystal BiotechKRYS · Health Care | 0.00% | ZAR 163.5B | ZAR 5,516.38 | 0.15% up | 49% up | ||
| 13 | VaxcytePCVX · Health Care | 0.00% | ZAR 161.4B | ZAR 1,019.37 | 0.27% down | 22% up | ||
| 14 | Twist BioscienceTWST · Health Care | 0.00% | ZAR 132.9B | ZAR 1,949.65 | 4.07% down | 291% up | ||
| 15 | CG OncologyCGON · Health Care | 0.00% | ZAR 127.8B | ZAR 1,430.54 | 2.38% up | 93% up | ||
| 16 | ImmunityBioIBRX · Health Care | 0.00% | ZAR 122.1B | ZAR 114.76 | 1.94% down | 216% up | ||
| 17 | ImmunovantIMVT · Health Care | 0.00% | ZAR 117.6B | ZAR 568.02 | 1.96% down | 44% up | ||
| 18 | Kodiak SciencesKOD · Health Care | 0.00% | ZAR 111.8B | ZAR 1,710.01 | 0.09% up | 371% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | 0.00% | ZAR 107.3B | ZAR 879.81 | 4.94% up | 25% up | ||
| 20 | Adaptive BiotechnologiesADPT · Health Care | 0.00% | ZAR 79.3B | ZAR 489.95 | 1.44% down | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4669 ZAR).
Questions and answers
Which biotech companies in the United States rank first by dividend yield?
Amgen (2.24%), Gilead Sciences (1.92%) and Bio-Techne (0.33%) are the top three of the 20 biotech companies in the United States ranked by dividend yield as of 20 Nov 2026, 12:08 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by dividend yield.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by dividend yield have a combined market value of ZAR 12.84T as of 20 Nov 2026, 12:08 UTC.
What does ranking by dividend yield measure?
Dividends paid over the last twelve months as a share of today's price.
Learn how this ranking works
All markets guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Biotech companies in the United States by dividend yield”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=dividend-yield
Underlying data: Yahoo Finance; SEC EDGAR.